Symptoms of Acute Coronary Syndrome in Medical Regulation - Trial NCT05902130
Access comprehensive clinical trial information for NCT05902130 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Régional Metz-Thionville and is currently Recruiting. The study focuses on Acute Coronary Syndrome. Target enrollment is 208 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Centre Hospitalier Régional Metz-Thionville
Timeline & Enrollment
N/A
Jan 01, 2023
Jul 01, 2023
Primary Outcome
Delay between the call to the emergency center and the first contact with a physician
Summary
The main objective was to analyze the impact of the gender of the attending physician in the
 differences in the management of ST+ ACS between men and women.
 
 This study will be conducted in partnership with the interventional cardiology team of the
 CHR Metz-Thionville and SAMU (emergency call center) of Moselle, which has a detailed
 registry of coronary angiographies at the center. A retrospective observational study will be
 carried out over a typical period outside of covid at the CHR Metz Mercy (2021-2022) based
 on coronary angiographies performed in the context of ST+ ACS at the CHR of patients referred
 by the center 15.
 
 The patient's medical record will be analyzed, going back to his call to the 15 via tape
 listening. The number of subjects required being calculated at 104 men and 104 women, these
 patients will be selected from the database of our cardiologist colleagues and we will match
 one man to one woman by comparing the delays of several items (1st medical contact, time of
 1st ECG, medicalization or not, delay of call to the cardiologist, delay of coronary
 angiography...) according to the sex of the regulator. The consequences of a difference in
 management will be also evaluated by analyzing in-hospital mortality, mortality at 30 days of
 management, and functional sequelae at discharge (grades of dyspnea, disturbance of
 myocardial contractility, LVEF at discharge).
 
 This study based on the differences in questioning according to the gender of the regulating
 physician would allow better identification of the factors that increase the delay in the
 management of ST+ ACS in women, and to find avenues of correction in order to limit the loss
 of opportunity for patients.
 
 The patients included who are still alive will receive a notification of non-objection by
 mail.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05902130
Non-Device Trial